Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
22.42
+0.37 (1.68%)
At close: Jan 9, 2026, 4:00 PM EST
22.60
+0.18 (0.80%)
After-hours: Jan 9, 2026, 7:39 PM EST
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.28 billion as of January 9, 2026. Its market cap has increased by 41.70% in one year.
Market Cap
3.28B
Enterprise Value
3.15B
1-Year Change
41.70%
Ranking
Category
Stock Price
$22.42
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.28B, an increase of 87.31%. That is a compound annual growth rate of 14.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.28B | -10.36% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |